...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: What's the deal with Zenith?
3
Jun 21, 2023 04:54PM
3
Jun 22, 2023 07:41AM
6
Jun 22, 2023 02:26PM
3
Jun 23, 2023 01:54AM
1
Jun 23, 2023 02:15AM
3
Jun 23, 2023 10:24AM
5
Jun 24, 2023 08:49AM

Toinv & tada ... I am not overcome with optimism & hope right now, nor delusional about the challeneges with the process or outcome. I am just glad that there is a "plan" and some creativity for progress, of some kind. Always maintain motion & initiative, rather than just sitting in the dark listening to country music swilling on Jack Daniels (not that anything is wrong with that at times), and hoping something changes.

And this actually seems "possible," with potential benefits for all, with/for the right BP ... characteristics of which have already been identified. I would give this a 30-40% chance off the cuff, which is better than just sitting on his thumb. And when talks are ongoing, there are many twists & turns that can take place. 

To me, anything that potentially links both Zenith and RVX together with a BP, is a good thing, and advancement.

Whether this specific concept comes to fruition, or a different one eventually comes to fruition, just keep it moving .... and keep RVX visible in discussions.

And I don't think he would be throwing things like this out there, unless he has already had some degree of "concept" talks jmho.

Share
New Message
Please login to post a reply